Search alternatives:
largest decrease » marked decrease (Expand Search)
values decrease » values increased (Expand Search)
larger decrease » marked decrease (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
largest decrease » marked decrease (Expand Search)
values decrease » values increased (Expand Search)
larger decrease » marked decrease (Expand Search)
ct values » _ values (Expand Search), i values (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
c larger » _ larger (Expand Search), c large (Expand Search), _ large (Expand Search)
-
141
Confusion matrices of (a-b) 60:40 of TRAP/TESP and (c-d) 70:30 of TRAP/TESP.
Published 2025Subjects: -
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
Effects of CGA on renal biochemical markers.
Published 2025“…<div><p>Diabetic nephropathy (DN) is the single largest cause of end-stage renal disease (ESRD). Inflammation reaction mediated by NLRP3 inflammasome and Nrf2-related oxidative stress have been considered to play a very important role in the progress of diabetic nephropathy (DN). …”
-
154
-
155
-
156
-
157
-
158
Data Sheet 1_Changes in pancreatic levodopa uptake in patients with obesity and new-onset type 2 diabetes: an 18F-FDOPA PET-CT study.docx
Published 2025“…</p>Results<p>Pancreatic levodopa uptake increased in obese patients with insulin resistance, whereas it decreased in obese patients with new-onset type 2 diabetes [standardized uptake value (SUV) mean in participants with normal weight, 2.6 ± 0.7; SUV<sub>mean</sub> in patients with obesity, 3.6 ± 0.1; SUV<sub>mean</sub> in patients with obesity and new-onset type 2 diabetes, 2.6 ± 0.1, P = 0.02].…”
-
159
-
160